ORAGENICS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ORAGENICS, INC. (OGEN) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$2.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-16
- ORAGENICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$2.10M.
- ORAGENICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$2.21M.
- ORAGENICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$4.34M.
- ORAGENICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$3.00M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$2.10M 10-K · filed 2026-03-16 | |
| 2024-12-31 | -$2.21M 10-K · filed 2025-03-14 | |
| 2023-12-31 | -$4.34M 10-K · filed 2025-03-14 | |
| 2022-12-31 | -$3.00M 10-K · filed 2024-03-29 | |
| 2021-12-31 | -$3.30M 10-K · filed 2023-04-17 | |
| 2020-12-31 | -$5.55M 10-K/A · filed 2022-07-29 | |
| 2019-12-31 | -$3.27M 10-K · filed 2021-03-01 | |
| 2018-12-31 | -$2.08M 10-K · filed 2020-03-04 | |
| 2017-12-31 | -$2.29M 10-K · filed 2019-03-29 | $2.29M 10-K · filed 2018-02-16 |
| 2016-12-31 | $2.38M 10-K · filed 2018-02-16 | |
| 2015-12-31 | $3.98M 10-K · filed 2017-02-27 | -$3.98M 10-K · filed 2016-03-30 |
| 2014-12-31 | -$1.97M 10-K · filed 2016-03-30 | |
| 2013-12-31 | -$5.46M 10-K · filed 2015-02-27 | |
| 2012-12-31 | -$4.45M 10-K · filed 2014-02-28 | |
| 2011-12-31 | -$2.61M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |